• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • NMPA Monthly Newsletter

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

China NMPA Newsletter – February 2023

2023-04-25

Featured Articles NMPA New Approvals in February 2023 In February 2023, NMPA approved 162 medical devices, including 19…

NMPA New Approvals In March 2023

2023-04-24

In March 2023, NMPA approved 290 medical devices, including 33 Class III imported products, 26 Class II imported…

China Released Measures For The Ethical Review Of Life Sciences And Medical Research Involving Human

2023-04-23

China authorities, including the National Health Commission (NHC), Ministry of Education, Ministry of Science and Technology and National…

NMPA Onsite Inspection On Manufacturers Or Legal Agent Without Submitting Annual Quality System Self-Inspection Report Since April 2023

2023-04-10

For manufacturers operating medical devices in China, NMPA has issued the deadline for submitting the 2022 Annual Quality…

NMPA Latest Announcement On Implementation Of China GB 9706.1-2020 And Related Standards On March 16, 2023

2023-03-19

NMPA released the latest announcement on the implementation key issues of the new China GB 9706.1-2020 and collateral…

NMPA Released The 45th Batch Of Medical Device Approvals For 2023

2023-03-17

On March 14, 2023, the NMPA issued the 45th batch of information on medical device approvals, including 9…

NMPA New Approvals In February 2023

2023-03-17

In February 2023, NMPA approved 162 medical devices, including 19 Class III imported products, 22 Class II imported…

CIMDR Insights On China Medical Device Regulatory Environment

2023-03-14

From March 1 to March 4, 2023, the 13th China International Medical Device Regulatory Forum (CIMDR) was held…

China NMPA Newsletter – January 2023

2023-02-28

Featured Articles NMPA New Approvals in January 2023 In January 2023, NMPA approved 124 medical devices, including 11…

NMPA Urgent Notice To Terminate The Extension Of Medical Device Registration Supplementary Phase

2023-02-24

Starting from 2020, impacted by the COVID-19, the China NMPA extended the supplemental phase for the medical device…

NMPA Innovative Medical Devices Registration And Approval Summary For Year 2022

2023-02-21

In 2022, NMPA conducted the review and approval of innovative medical devices and clinically urgent use medical devices…

NMPA New Approvals In January 2023

2023-02-16

In January 2023, NMPA approved 124 medical devices, including 11 Class III imported products, 12 Class II imported…
« Prev...2...56789...121416...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7